165 related articles for article (PubMed ID: 24403468)
41. Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis.
Cai W; Wang ZT; Zhong J; Zhang Y
Genet Mol Res; 2013 Apr; 12(4):6636-45. PubMed ID: 23661400
[TBL] [Abstract][Full Text] [Related]
42. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
[TBL] [Abstract][Full Text] [Related]
43. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
Muñoz-Guerra MF; Fernández-Contreras ME; Moreno AL; Martín ID; Herráez B; Gamallo C
Ann Surg Oncol; 2009 Aug; 16(8):2351-8. PubMed ID: 19449077
[TBL] [Abstract][Full Text] [Related]
44. Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma.
Yu C; Lu W; Tan W; Xing D; Liang G; Miao X; Lin D
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):176. PubMed ID: 12582032
[No Abstract] [Full Text] [Related]
45. Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma.
Kämmerer PW; Koch FP; Schiegnitz E; Kumar VV; Berres M; Toyoshima T; Al-Nawas B; Brieger J
J Oral Pathol Med; 2013 May; 42(5):374-81. PubMed ID: 23227881
[TBL] [Abstract][Full Text] [Related]
46. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
47. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
[TBL] [Abstract][Full Text] [Related]
48. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers.
Liu HS; Lu HH; Lui MT; Yu EH; Shen W; Chen YP; Chang KW; Tu HF
Oral Oncol; 2009 Dec; 45(12):1032-6. PubMed ID: 19666237
[TBL] [Abstract][Full Text] [Related]
49. Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients.
Song JH; Kim CJ; Cho YG; Park YK; Nam SW; Yoo NJ; Lee JY; Park WS
Neoplasma; 2007; 54(3):235-9. PubMed ID: 17447856
[TBL] [Abstract][Full Text] [Related]
50. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis.
Meng Y; Zhang C; Zhou X
Onco Targets Ther; 2016; 9():367-76. PubMed ID: 26855585
[TBL] [Abstract][Full Text] [Related]
51. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
52. An update on the implications of cyclin D1 in oral carcinogenesis.
Ramos-García P; Gil-Montoya JA; Scully C; Ayén A; González-Ruiz L; Navarro-Triviño FJ; González-Moles MA
Oral Dis; 2017 Oct; 23(7):897-912. PubMed ID: 27973759
[TBL] [Abstract][Full Text] [Related]
53. Effect of cyclin [corrected] D1 (CCND1) gene polymorphism on tumor formation and behavior in patients with prolactinoma.
Cander S; Ertürk E; Karkucak M; Oz Gül O; Görükmez O; Yakut T; Unal OK; Ersoy C; Tuncel E; Imamoğlu S
Gene; 2012 Nov; 509(1):158-63. PubMed ID: 22967707
[TBL] [Abstract][Full Text] [Related]
54. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
[TBL] [Abstract][Full Text] [Related]
55. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.
Ceschi M; Sun CL; Van Den Berg D; Koh WP; Yu MC; Probst-Hensch N
Carcinogenesis; 2005 Aug; 26(8):1457-64. PubMed ID: 15845652
[TBL] [Abstract][Full Text] [Related]
56. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
[TBL] [Abstract][Full Text] [Related]
57. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
[TBL] [Abstract][Full Text] [Related]
58. Cyclin D1 protein tissue detection in laryngeal cancer.
Segas JV; Lazaris AC; Nikolopoulos TP; Kavantzas NG; Lendari IE; Tzagkaroulakis AM; Patsouris ES; Ferekidis EA
ORL J Otorhinolaryngol Relat Spec; 2005; 67(6):319-25. PubMed ID: 16327270
[TBL] [Abstract][Full Text] [Related]
59. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.
Abramson VG; Troxel AB; Feldman M; Mies C; Wang Y; Sherman L; McNally S; Diehl A; Demichele A
Anticancer Res; 2010 Apr; 30(4):1279-85. PubMed ID: 20530440
[TBL] [Abstract][Full Text] [Related]
60. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
Wang S; Huang Y; Su R; Fang Z; Han M
Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]